<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>DARU Journal of Pharmaceutical Sciences</JournalTitle><Volume>10</Volume><Issue>1</Issue></Journal><ArticleTitle>"Interaction of different doses of Aspartame with Morphine-induced antinociception in the presence of MK-801, a NMDA antagonist "</ArticleTitle><FirstPage>9</FirstPage><LastPage>16</LastPage><AuthorList><Author><FirstName></FirstName><LastName>Abdollahi M</LastName></Author><Author><FirstName></FirstName><LastName>Aghabarati F</LastName></Author><Author><FirstName></FirstName><LastName>Nikfar Sh</LastName></Author><Author><FirstName></FirstName><LastName>Etemad F</LastName></Author><Author><FirstName></FirstName><LastName>Abdoli N</LastName></Author></AuthorList><History><PubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>06</Day></PubDate></History><Abstract>This study was designed to investigate the relative role of sweetness and comparative effects of different taste sensation of the non - caloric sweetener , aspartame on pain and its interaction with MK - 80] as a non - selective MMDA antagonist by formalin - test in mice. The formalin - test was chosen because it measures the response to a long - lasting nociceptive stimulus and closely resembles to the clinical pain. Morphine induced a dose dependent antinociception in the early and late phases of formalin test. Twelve days pretreatment of animals by aspartame ( 0.08% , 0.16% , 0.32%) significantly potentiated morphine - induced (1.5-9 mg/kg) analgesia in the early phase but significantly antagonized its analgesic effect in the late phase, dose dependently. Aspartame (0.16%) alone showed a reduction in pain response . Naloxone (0.4 mg/kg) significantly antagonized the antinociceptive effect of morphine in the presence of aspartame (0-0.32%) in the early phase. Increasing the dose of aspartame decreased effects of naloxone. MK-801 (0.1 mg/kg) as an N- Methyl - D - Aspartate (NMDA) antagonist significantly potentiated the effect of aspartame on morphine - induced antinociception in the early phase. In the late phase, naloxone (0.4 mg/kg) increased pain response but MK- 801 (0.1 mg/kg) induced anti-inflammatory effect significantly. Treatment of animals with MK- 801 alone, significantly induced analgesia in both phases of formalin - test. This effect was potentiated with aspartame dose - dependently. Possible interaction of aspartame with NMDA receptors and its role to facilitate endogenous opioid system are proposed mechanisms of aspartame in modulating morphine - induced antinociception. Furthermore, the resulting association between morphine and aspartame chronic consumption may be explained as an interactive action rather than simple dose combination of both drugs.</Abstract><web_url>https://daru.tums.ac.ir/index.php/daru/article/view/133</web_url><pdf_url>https://daru.tums.ac.ir/index.php/daru/article/download/133/133</pdf_url></Article></Articles>
